+ 0.00
+ 0%
+ 0.02
+ 0.01%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.01
+ 0.01%

Why Taysha Gene Therapies's Stock is Trading Higher Today

April 12, 2021 10:54 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The Price And Volume Action In Taysha Gene Therapies's Stock Today

Taysha Gene Therapies's (NASDAQ:TSHA) stock is trading up 18.73% to a price of $25.74. The stock's current volume for the day is 258.38 thousand, which is approximately 286.81% of its previous 30-day average volume of 90.09 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Taysha Gene Therapies shares are trading higher after the company announced the acquisition of exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of giant axonal neuropathy.

Perspective On Recent Price Action

The stock's 50-day moving average was $25.67 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $33.35 and fallen to a low of $18.16.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.


Movers Trading Ideas

Related Articles

55 Biggest Movers From Yesterday

Gainers read more

What's Going On With MOSY Stock And TSHA Stock?

MoSys Inc. (NASDAQ: MOSY) shares are trading higher after the company announced it has expanded its patent portfolio through the purchase of five patents in the area of search and classification algorithms. read more

12 Health Care Stocks Moving In Monday's Intraday Session

  read more

42 Stocks Moving In Monday's Mid-Day Session

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake of 18.4% in the company on Friday. read more